Viewing data from:

BENZONATATE

ANDA

BENZONATATE | A211518 | ASCENT PHARMACEUTICALS INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: TESSALON(TE code: AA)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.1046

per ea

Lowest NADAC/Unit

$0.0708

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
31722095801BENZONATATE 200 MG CAPSULE	$0.1046	EA	Generic	—	2026-06-17
31722095805BENZONATATE 200 MG CAPSULE	$0.1046	EA	Generic	—	2026-06-17
31722095601BENZONATATE 100 MG CAPSULE	$0.0708	EA	Generic	—	2026-06-17
31722095605BENZONATATE 100 MG CAPSULE	$0.0708	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 4 NDCs (4 FSS)

Lowest Price

$2.50

Highest Price

$13.50

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
72865-0117-01BENZONATATE 100MG CAP	$7.95	FSS	XLCare Pharmaceuticals, Inc.	05/31/2026
72865-0117-30BENZONATATE 100MG CAP	$2.50	FSS	XLCare Pharmaceuticals, Inc.	05/31/2026
72865-0119-01BENZONATATE 200MG CAP	$13.50	FSS	XLCare Pharmaceuticals, Inc.	05/31/2026
72865-0119-30BENZONATATE 200MG CAP	$4.50	FSS	XLCare Pharmaceuticals, Inc.	05/31/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain4 active DMFs1 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

W R GRACE AND CO -CONNBENZONATATE USP

DMF 51961983

SIEGFRIED EVIONNAZ SABENZONATATE

DMF 78431988

FORMOSA LABORATORIES INCBENZONATATE USP

DMF 217032008

AMI LIFESCIENCES PRIVATE LTDBENZONATATE

DMF 390022023

KINGLAND CHEMICALS CO LTDInactiveBENZONATATE

DMF 241942010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 100MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Feb 22, 2019

No patent or exclusivity listings for this strength.

#002 — 150MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 22, 2019

#003 — 200MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Feb 22, 2019